DEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding Rx
Published November 3, 2021 · Recall initiated: August 13, 2021
Summary
FDA records drug Class II recall D-0036-2022, published November 3, 2021 and initiated August 13, 2021. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: N/A; Lot: all lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Distributor
- 494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.
- Lot
- all lots within expiry
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding RxNovember 3, 2021
- FDATEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAMETHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDATEST CYP 200MG/ML IN SESAME OIL MDV, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDACYCLOSPORINE 2% MCT OIL SUSP, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAESTRADIOL VALERATE 5MG/ML MDV INJ, Rx only, Red Mountain Compounding RxNovember 3, 2021
Questions about this recall
Was DEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding Rx recalled?
Yes. FDA published recall D-0036-2022 on November 3, 2021. Reported hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
What should I do if I have this product?
Voluntary: Firm initiated